Wei Wu, Phd's Location
San Francisco Bay Area, United States, United States
Wei Wu, Phd's Contact Details
Wei Wu, Phd work email
- Valid
- Valid
- Valid
- Valid
- Valid
Wei Wu, Phd personal email
n/a
Wei Wu, Phd phone numbers
About Wei Wu, Phd
Wei Wu, Phd is a Biotech Executive / Healthcare Investor at Johnson & Johnson. They possess expertise in molecular biology, genetics, cell culture, molecular cloning, cell biology and 15 more skills.
Wei Wu, Phd's Current Company Details
Wei Wu, Phd Work Experience Details
-
Senior Director, Venture Investments, JjdcJohnson & Johnson Feb 2021 - PresentNew Brunswick, Nj, UsJJDC is the strategic corporate venture capital group for Johnson & Johnson; launched in 1973, it is one of the longest-running and most reputable CVC in health care. I cover investments in areas of strategic interest to Johnson & Johnson. In support of J&J strategic objectives, I work closely with Innovation Centers, JLabs, Therapeutic Areas, Business Development, Commercial, and R&D Functional Areas.2022-2023, Global assignment in Shanghai China
-
Board MemberCircode Biomed 2023 - PresentCircode develops novel RNA therapeutics for multiple disease areas
-
Board ObserverDac Biotech 2022 - PresentDAC Biotechnology is an antibody-drug-conjugate (ADC) company that has established an end-to-end capability for ADC generation and an innovative pipeline in pre-clinical and clinical stages.
-
Board MemberImmpact Bio Usa Inc Jan 2021 - Dec 2021West Hills, California, UsImmPact Bio is pioneering a novel strategy to surmount a major challenge compromising current T-cell (CAR-T) therapy.Acquired by Lyell Immunopharma (LYEL) in 2024. -
Board ObserverActym Therapeutics, Inc. 2020 - 2021Berkeley, Ca, UsActym Therapeutics is developing a microbial-based immunotherapy platform for various challenging cancer types. -
Senior AssociateIllumina Ventures 2019 - 2021Illumina Ventures is an independently managed fund focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. We invest in life science tools, therapeutics, clinical diagnostics, and other opportunities to improve human health.Covered investments: Actym Therapeutics, Kallyope, Encoded Therapeutics. -
Advisory Board MemberCura Therapeutics 2019 - 2020Immunotherapies for cancer
-
Director, Healthcare Investment And Business DevelopmentBoe Technology Group Co., Ltd. 2017 - 2019Beijing, CnBOE Technology Group is a FORBES global2000 company headquartered in Beijing, China. -Lead all aspects of sourcing and deal execution in healthcare business-Manage collaboration projects, investment portfolio, and LP-GP relationship-Recruitment, training, and team building-Corporate strategy and business development-PR/marketing/ecosystem expansion -
Board ObserverCeribell, Inc 2017 - 2019Sunnyvale, California, UsCeribell is focused on making EEG widely accessible, drastically more efficient, and more cost-effective to improve the diagnosis and treatment of neurological patients.IPO in 2024 -
Board ObserverBaebies 2017 - 2019Durham, Nc, UsBaebies, guided by the vision that “everyone deserves a healthy start,” delivers innovative products and services for newborn screening and pediatric testing. -
Co-Chair, Biotech/Genomics Investment CommitteeLife Science Angels Jan 2017 - Dec 2018Sunnyvale, Ca, UsLife Science Angels is the premier angel investment group investing in medical devices, diagnostics, pharmaceuticals, biotechnology, genomics, and digital health. It's ranked as the top 1/350 angel investment groups in US by CB Insights in 2014. Typical investments range from $200-$600k, with syndicated financings ranging to $2-3M. - Lead a team of fellows to source deals, conduct due diligence, manage deal flows, prepare deal memo, negotiate deal terms, and organize deal screening meetings.- Manage relationship between start-up and angel investors.- Advise angels on investment decision; Advise entrepreneurs on investor pitch and provide constructive feedback.- Recruit, train, and manage new fellows; Recruit new investor members.- Syndicate with device/digital health committee and other investor groups.Instrumental to LSA investment in: Mission Bio, Seal Rock Therapeutics, Noctrix Health -
Senior Fellow In Entrepreneurship - Biotech/Genomics Investment CommitteeLife Science Angels Jan 2016 - Jan 2017Sunnyvale, Ca, Us
-
Scientist, Project LeadTecan Genomics, Inc. 2015 - 2017Männedorf, Zh, ChNuGEN Technologies was acquired by TECAN to become TECAN Genomics. - Technical lead of cross-functional core team to research and develop a broad spectrum of Next-Generation-Sequencing based technologies and products- Collaborate on projects with research institutes and biopharmaceutical companies worldwide. -
Postdoctoral Fellow, Gerald R. Crabtree LabStanford University School Of Medicine Jan 2012 - Jul 2015Palo Alto, Ca, UsDepartment of Pathology and Developmental Biology, Stanford University/Howard Hughes Medical Institute:- Led 2 projects to understand the molecular mechanisms of developmental and induced neurogenesis for modeling human neurologic diseases and developing better therapeutic strategies. - Published 3 articles in high-profile scientific journals including Nature Reviews Genetics.- Helped advisor to obtain 1.4M funding from California Institute of Regenerative Medicine (CIRM).- Invited to review and serve as an editorial board member for multiple international scientific journals -
Invited Guest EditorCell Adhesion & Migration, Landes Bioscience Jun 2012 - Aug 2013- Initiated, coordinated and organized special focus issue "cell adhesion in axon growth"- Managed peer-review process and made expert recommendation to the editor-in-chief- Wrote editorial previews
-
Graduate Research Associate, S.Lawrence Zipursky LabUniversity Of California, Los Angeles Sep 2005 - Dec 2011Los Angeles, Ca, UsDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA/Howard Hughes Medical Institute:- Studied the structure and function of a homologue of human Down Syndrome Cell Adhesion Molecule in controling neural circuit assembly using Drosophila as the model system.- Published 4 original articles in top-tier scientific journals including Cell, Nature, and Neuron.- Invited to present talks and posters at prestigious international conferences in countries including US, Japan, and China. -
Business Development Analyst, Ucla Technology Transfer OfficeUniversity Of California, Los Angeles 2009 - 2010Los Angeles, Ca, Us- Evaluated invention disclosures from UCLA inventors, performed market research, and drafted non-confidential disclosures- Served as the liaison between UCLA inventors and industry, and worked with licensing team to commercialize inventions
-
Graduate Teaching AssistantUniversity Of California, Los Angeles 2007 - 2008Los Angeles, Ca, Us- Molecular Biology, Life Science Core Curriculum for Undergraduates, 2008- Genetics, Life Science Core Curriculum for Undergraduates, 2007
-
Undergraduate Research AssistantPeking-Yale Joint Center For Plant Molecular Genetics And Agrobiotechnology Aug 2003 - Jun 2005- Studied the role of a MYB transcription factor in regulating circadian rythym of Arabidopsis.
Wei Wu, Phd Skills
Molecular Biology
Genetics
Cell Culture
Molecular Cloning
Cell Biology
Biochemistry
Research
Western Blotting
Fluorescence Microscopy
Confocal Microscopy
Neuroscience
Genomics
Qpcr
Elisa
Regenerative Medicine
Next Generation Sequencing
Due Diligence
Epigenetics
Stem Cell Research
Structural Biology
Wei Wu, Phd Education Details
-
Stanford UniversityPathology | Healthcare Business And Finance -
UclaBiological Chemistry
-
Peking UniversityBiological Sciences
-
The Wharton SchoolNegotiation And Influence
-
China Europe International Business School (Ceibs)Executive Mba Program: Strategic Negotiation
Frequently Asked Questions about Wei Wu, Phd
What company does Wei Wu, Phd work for?
Wei Wu, Phd works for Johnson & Johnson
What is Wei Wu, Phd's role at the current company?
Wei Wu, Phd's current role is Biotech Executive / Healthcare Investor.
What is Wei Wu, Phd's email address?
Wei Wu, Phd's email address is wu****@****cla.edu
What is Wei Wu, Phd's direct phone number?
Wei Wu, Phd's direct phone number is +140854*****
What schools did Wei Wu, Phd attend?
Wei Wu, Phd attended Stanford University, Ucla, Peking University, The Wharton School, China Europe International Business School (Ceibs).
What are some of Wei Wu, Phd's interests?
Wei Wu, Phd has interest in Table Tennis, Cooking, Latin Dancing, Travelling, Dancing, Photography, Piano, Singing.
What skills is Wei Wu, Phd known for?
Wei Wu, Phd has skills like Molecular Biology, Genetics, Cell Culture, Molecular Cloning, Cell Biology, Biochemistry, Research, Western Blotting, Fluorescence Microscopy, Confocal Microscopy, Neuroscience, Genomics.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial